InsiderFlow

Steve E. Krognes

DNLI

Steve E. Krognes serves as Director at Denali Therapeutics Inc. (DNLI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

18 trades

$8.02M

Net Position

Net Seller

$8.02M

Companies Traded

1

DNLI

Active Period

Mar 2021 – Jan 2025

18 total trades

Most Recent

Sell DNLI

Jan 8, 2025 · $69.5K

Steve E. Krognes's Insider Trading at Denali Therapeutics Inc. (DNLI)

Buys

0 · $0.00

Sells

18 · $8.02M

Total Shares Bought

0

Total Shares Sold

262,716

DNLI Price Chart
Loading chart...
DateTypeValue
Jan 8, 2025 Sell$69.5K
Jan 3, 2025 Sell$607.5K
Oct 2, 2024 Sell$870.9K
Aug 22, 2024 Sell$41.1K
Jul 3, 2024 Sell$678.7K
Apr 2, 2024 Sell$1.90M
Feb 15, 2024 Sell$47.5K
Jan 9, 2024 Sell$62.3K
Aug 23, 2023 Sell$32.1K
Feb 15, 2023 Sell$63.8K
Feb 10, 2023 Sell$42.5K
Jan 9, 2023 Sell$84.5K
Aug 23, 2022 Sell$74.8K
Feb 15, 2022 Sell$88.8K
Feb 11, 2022 Sell$48.1K
Jan 7, 2022 Sell$99.6K
Aug 23, 2021 Sell$113.3K
Mar 16, 2021 Sell$3.09M